Form 4: Humana Executive Vishal Agrawal Reports Stock Transactions
SEC Form 4 Filing
Humana's Chief Strategy and Corporate Development Officer, Vishal Agrawal, reports the vesting and tax withholding of restricted stock units and the acquisition of shares through option exercises.
Summary
- Vishal Agrawal, Chief Strategy and Corporate Development Officer at Humana, filed a Form 4 detailing several transactions involving Humana stock.
- On December 15, 2024, Agrawal had 205 shares withheld to cover tax liabilities from vested restricted stock units at a price of $271.675 per share.
- He also had 140 shares withheld for tax liabilities at the same price on the same day.
- Additionally, 309 and 310 restricted stock units vested, resulting in the acquisition of 309 and 310 shares respectively.
- Agrawal also exercised options to acquire 309 and 310 shares of Humana stock.
- Following these transactions, Agrawal directly owns 12,382 shares of Humana common stock, including 908 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing standard stock transactions, with no indication of positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the stock transactions of company insiders.
Comparison to Industry Standards
- The vesting of restricted stock units and exercise of stock options are common forms of executive compensation in publicly traded companies like Humana.
- The tax withholding of shares is a standard practice when restricted stock units vest.
- Other healthcare companies such as UnitedHealth Group (UNH) and CVS Health (CVS) also regularly report similar insider transactions.
Stakeholder Impact
- The transactions have a minor impact on the total outstanding shares of Humana.
- The filing provides transparency to shareholders regarding executive stock ownership.
Key Dates
| Date | Description |
|---|---|
| 12/11/2018 | Incentive & Non-Qualified stock options granted to reporting person, vesting in three increments from 12/11/19 to 12/11/21. |
| 02/25/2019 | Incentive & Non-Qualified stock options granted to reporting person, vesting in three increments from 02/25/20 to 02/25/22. |
| 02/24/2020 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/24/21 to 2/24/23. |
| 02/22/2021 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/22/22 to 2/22/24. |
| 02/21/2022 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/21/23 to 2/21/25. Restricted stock units granted, 33% vesting on 12/15/22, 12/15/23, and 12/15/24. |
| 02/24/2023 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/24/24 to 2/24/26. Restricted stock units granted, 33% vesting on 12/15/23, 12/15/24, and 12/15/25. |
| 02/21/2024 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/21/25 to 2/21/27. |
| 12/15/2024 | Date of stock transactions including vesting of restricted stock units and tax withholding. |
| 12/17/2024 | Date of filing of the Form 4. |
Keywords
Humana, stock transactions, Form 4, insider trading, restricted stock units, stock options, executive compensation, Vishal Agrawal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.